Sonnet BioTherapeutics Pivots Into Crypto With $888M Hyperliquid Treasury Strategy
Nasdaq-listed biotech firm Sonnet BioTherapeutics is making a bold move into the digital asset space, unveiling plans to launch an $888 million Hyperliquid (HYPE) token treasury under a newly formed entity.
Nasdaq-listed biotech firm Sonnet BioTherapeutics is making a bold move into the digital asset space, unveiling plans to launch an $888 million Hyperliquid (HYPE) token treasury under a newly formed entity.
On Monday, Sonnet announced it had entered into a business combination with Rorschach, a company it recently created, to spearhead its new crypto-focused strategy. This move will see Sonnet transform into Hyperliquid Strategies Inc. (HSI), positioning it as the largest publicly traded U.S. company to hold HYPE tokens on its balance sheet.
HSI intends to acquire 12.6 million HYPE tokens, worth approximately $583 million at the time of the agreement. Alongside this, it will hold $305 million in cash reserves, bringing the total value of the entity to $888 million. The company also hinted that part of its cash reserves will be used to purchase additional HYPE tokens going forward.
Hyperliquid, the token at the centre of this pivot, powers a high-throughput layer-1 blockchain designed for onchain trading of perpetual futures and other advanced financial instruments. According to CoinGecko, Hyperliquid currently ranks as the 12th-largest token globally, boasting a market capitalization of $16.2 billion.
Source:
CoinGhecko
By creating HSI, Sonnet offers traditional equity investors indirect exposure to HYPE, bridging the gap between conventional finance and emerging blockchain technologies. This strategy mirrors the approach of Strategy, the business intelligence firm that famously pivoted into Bitcoin investments, giving stock market investors exposure to crypto without direct token purchases.
The initiative is backed by heavyweight institutional investors including Atlas Merchant Capital, Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital. Paradigm co-founder Matt Huang described Hyperliquid as a crypto project with robust fundamentals, noting growing institutional appetite for HYPE exposure despite its limited accessibility in the U.S.
Similarly, Eyenovia, Inc., a Nasdaq-listed ophthalmic technology company, announced a significant $50 million investment in Hyperliquid’s native cryptocurrency, HYPE.
While Sonnet undergoes this significant transformation, it will continue operating its clinical oncology portfolio under HSI’s corporate umbrella.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. inflation remains “persistently high”! Goldman Sachs changes its stance: The Federal Reserve’s rate hike cycle is not over yet, another 25 basis points increase possible in March next year
Higher-than-expected US October CPI data released on Tuesday prompted Goldman Sachs to revise its previous forecast that the Fed’s current rate hike cycle would end in December. The Wall Street financial giant now expects the Fed to raise interest rates by another 25 basis points in March next year.
VeChain Eyes a Bullish Reversal as VET Targets $0.018 After Key Support Test

Fear is the biggest short! Morgan Stanley calls for bottom-fishing in semiconductors: land and electricity shortages are not a problem, approved projects can't meet demand
Morgan Stanley believes that the recent sell-off in the semiconductor sector has been excessive, and that market panic rather than fundamentals is the biggest risk. Driven by demand for AI infrastructure, downstream orders continue to accelerate, with semiconductor supply remaining the core bottleneck. LPS constraints actually make growth more stable. The sector may fluctuate within a range in the short term and is currently near the bottom; prospects for the computing power and storage subsectors are favorable.

Indian Rupee extends rally amid continued FIIs buying, lower oil prices

